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Investigations on 24-hr urines in idiopathic stone formers, Ch. Riess,
B. Hess, and U. Binswanger. Nephrologische Station, Departement für
Innere Medizin, Universitdt Zurich, Switzerland. Concentrations and
activity products for calcium oxalate and other constituents of stones
were obtained from 24-hr urine collections in 43 idiopathic male calcium
oxalate stone formers. Results were compared with data of age-
matched healthy blood donors.
Urine excretion
mmole/24 hr Stone formers Controls
Calcium 6.3 2.9 7.3 2.2
Oxalate 0.39 0.14 0.40 0.15
Phosphate 28.5 10.9 36.4 10.8
Magnesium 4.0 1.7 5.5 1.7
Uric acid 3.1 1.2 2.8 1.2
Activity product 4.0 10—s 1.9 l0_ 3.2 10 l.4 10-8
aCa.aOx, mm2*
Mean SD.
* Calculated by Nomograms of Robertson.
No differences of the quantity of mineral in the urine excreted during 24
hr and of the activity product for calcium oxalate can be shown between
patients and controls. The pathophysiologic role and diagnostic mean-
ing of such measurements must be questioned on the basis of these
findings.
Evaluation of weekly protein catabolic rate by dialysis: Direct quanti-
lication in chronically haemodialyzed patients. P. Aebischer, D.
Schorderet, A. Juillerat, and G. Fe/lay. Centre d'hémodialyse, Service
de médecine interne, Hôpital cantonal de Fribourg, Switzerland.
Protein catabolic rate (PCR) has become an important and accessible
parameter in order to control urea levels and to adapt dialysis in
prescription. PCR was evaluated by dialysis direct quantification over
an entire week in 16 chronically haemodialyzed patients (12 men, 4
women) treated for 557 +I 83 mm per week for at least 10 months.
This method requires the collection of the total amount of spent
dialysate. None of the 16 patients were clinically either in catabolic or
anabolic state during the study. We could therefore assume that PCR
was equivalent to dietary protein intake. Mean weekly PCR was 1.0
+1— 0.19 g/kglday; three patients showed a value lower than 0.8
glkg/day, one higher than 1.4 g/kg/day. There was no significant
difference of mean weekly PCR between men (0.99 +1— 0.21 glkglday)
and women (1.04 +1— 0.10g/kg/day) (F> 0.5). Mean weekly PCR was
0.98 +1— 0.21 g/kg/dayforpatientsover6oyearsold(N= 11), 1.01 +1—
0.14 g/kg/day for patients under 60 years old (N = 5) (P> 0.5). There
was no significant mean PCR difference between short interdialytic
intervals (1.03 +1— 0.19 g/kg/day) and the long interdialytic interval
(0.97 0.22 glkg/day) (P > 0.5). The mean percentage of each
patient's maximal difference over an entire week was 15.1 +1— 8.2%.
Linear correlation coefficients among the 3 consecutive determinations
of PCR were: rl2: 0.86; r13: 0.70; r23: 0.75, showing only minimal
patient variability. Conclusions: 1) protein catabolic rate and therefore
dietary protein intake of our patients is in accordance with the recom-
mended values; 2) sex, age, and duration of interdialytic interval do not
seem to influence dietary protein intake; 3) for each individual patient,
variation of dietary protein intake over an entire week appears small,
suggesting that in order to control urea levels there is no need to adapt
dialysis prescription for each dialysis.
Pressure controlled single-needle hemodialysis using high flow dialyzers
and volume regulated untrafiltration: The problem of dialysate back flow.
M. Zbinden and U. Binswanger. Nephrologische Station, Departement
für Innere Medizin, Universitätsspital Zurich, Switzerland. In order to
prevent excessive ultrafiltration by high flow dialyzers (Fresenius F6o,
ultrafiltration 40 mI/h mm Hg), the pressure setting in the dialysate
compartment is less than applied in conventional filters. Because of
blood pressure drop across the dialyser, a gradient from dialysate to
blood with consecutive back flow of dialysate can occur, unless a low
dialysate pressure with a concomitant ultrafiltration rate of at least 1200
cc/hr is prescribed. For single-needle dialysis by means of a double
head pump, minimal ultrafiltration preventing back flow was found to
amount to 3000 cc/hr. This high ultrafiltration occurs because of
intermittent very low pressure in the blood compartment at times of
emptying of the filter by the venous pump. Therefore, back flow of
dialysate is prevented by low dialysate pressure, resulting in high
ultrafiltration rates that impose substitution (hemodiafiltration). Toler-
ance of back flow after bacterial filtering of the dialysate and testing of
dialysers for leads by means of automated reuse equipment is an
alternative that must be explored.
Nine months of experience with continuous veno-venous hemofiltration
(CVVH) in a surgery intensive care unit. F. Louis, P. Suter, P. Ruedin,
and H. Favre. Division de Nephrologie, Service des Soins Intenstfs de
Chirurgie, Hôpital Cantonal Universitaire de Genève, Genève, Swit-
zerknd. Continuous hemofiltration has been proposed recently as the
method of choice for the management of severely ill patients with acute
renal failure. Eleven patients (mean age 59 2.2 yrs) were treated by
CVVH during the last 9 months. Seven patients had major complica-
tions after abdominal surgery, two presented cardiogenic shock, and
two had multiple injuries. Ten of 11 patients had ventilatory assistance,
nine of 11 received catecholamine drugs to sustain their cardiac
function. Mean blood pressure (BP) before CVVH averaged 100 3/73
5 mm Hg, and did not change with initiation of the procedure. Two
catethers were percutaneously inserted into one femoral vein. The
blood was circulated through an hemofilter by a pump at a rate of 150
mi/mn. The extracorporeal system was secured for air embolism by an
air detector and an automatic venous clamp. Anticoagulation was
accomplished by a continuous perfusion of heparin at a rate of 500—700
UI/hr at the arterial injection port. Replacement fluid (modified Ringer's
solution) was infused into the venous line by a constant infusion pump.
On the average, hemofilters were changed every 3 days. No major
bleeding problems occurred. An ultrafiltration of 1000 to 1300 mi/Hr
was obtained, which corresponded to a mean creatinine of 20 mI/mn.
Mean duration of CVVH was 175,8 44 hr. Before the procedure,
mean serum urea and creatinine were 29,44 5 mmole/liter and 460
62 mol/liter, respectively; these values fell to 18,8 3 mmoie/liter (P
<0.025) and 220 37 mo1Iliter (P < 0.0025) during the first 3 days and
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remained so thereafter. Recovery of renal function occured in five of 11
patients. Global mortality was 63%, none of the deaths being related to
the procedure or metabolic disorders. Advantages of CVVH compared
to continuous arterio-venous hemofiltration (CAVH) are: a) a higher
filtration rate (1300 mI/hr vs. 500 mI/h), which is independent of the BP
in the former method; b) no need for arterial puncture. Both CVVH and
CAVH provide a better control of the ECFV and ease the global
management of this type of patient that is, parenteral nutrition and drug
administrations with their vehicles.
Erthrocytosis after kidney allotranspiantation: Hematological charac-
terization and complications. U. Keusch, H. Jungbluth, J. Fe/-ir, and U.
Binswanger. Nephrologische Station und Abteilung für Hamatologie,
Departement für Innere Medizin, Universitdt,cspital, Zurich, Zurich,
Switzerland. Erythrocytosis (E) is observed in 9 to 21% of kidney
allograft recipients. The etiology remains speculative and the reported
associated frequency of thromboembolic events is variable. We there-
fore analyzed 15 patients (pts) with E (defined as hematocrit of greater
than or equal to 50%) in a prospective study since 1979. For identifica-
tion of mechanisms involved, red cell mass (RCM) and plasma volume
(PV) were estimated. All values are expressed as means SD. Results:
E occurred 8.1 (range 1 to 30) months following kidney transplantation
(KT). No pts had undergone bilateral nephrectomy before KT. The
average serum creatinine at onset of E was 113 34 mol/1iter. Ten pts
experienced one to three acute rejection episodes. Hemoglobin and
hematocrit amounted to 17.4 1.3 g/dl and 54.3 5.5%, respectively.
RCM was elevated in 14 of 15 pts, amounting to 35.2 8.4 mI/kg body
wt, reflecting an increase of 40.4 (range 7 to 109) % as compared to
normal values. PV was increased in four pts and decreased in 11.
Arterial blood gases (obtained in seven pts) were normal in all pts. No
pts had coincidental thrombocytosis and leukocytosis. There was a
positive correlation between hematocrit and RCM (r = 0.69; P < 0.01).
Peripheral thrombosis was observed in four pts, leading to pulmonary
embolism in one. No relationship could be established between
thrombosis and hematological parameters. Therpeutic phlebotomy
maintaining hematocrit levels below 55% were able to prevent further
thrombotic complications. At the end of the follow-up period (7 to 80
months after onset of B), serum creatinine (119 47 imo1/1iter),
hemoglobin (16.1 0.9 g/dl) and hematocrit (50.8 2.8%) were not
changed significantly. Conclusions: E after kidney allotransplantation is
due to an increased RCM. E can be associated with thromboembolic
complications. In our series, E was associated with an excellent
allograft function.
Inhibition of parathyroid hormone (PTH) secretion and PTH-indepen-
dent diminution of tubular Ca reabsorption by WR-272l, a unique
hypocalcemic agent. S. Hirsche!-Scholz, J. Caverzasio, and J.-Ph.
Bonjour, Division de Physiopathologie, Departement de Medecine,
Hopital Canional Universitaire, Geneve, Switzerland. WR-2721 (S-,2-
((3-aminopropyl)amino)-,ethylphosphorothioic acid) is a compound
providing protection of normal tissues against radio- and chemotherapy
after being dephosphorylated in its active form. Normocalcemic pa-
tients treated with WR-2721 display hypocalcemia with decreased
plasma PTH. In a clinical investigation, we have observed that WR-
2721 can also suppress aberrant PTH secretion in a case of parathyroid
carcinoma. In experimental investigations we have studied the mecha-
nism of the hypocalcemic effect of WR-272l. The results show that in
intact rats 2 hr after injecting WR-2721 (0.7 mmol/kg body wt s.c.)
plasma Ca was 1.71 0.02 vs. 2.36 0.03 mM (P<0.00l) and urinary
cyclic AMP 38.2 3.1 vs. 70.5 6.3 pmoles/ml GFR (P < 0.01) in
solvent injected control animals. These data are consistent with inhibi-
tion of PTH secretion. In thyroparathyroidectomized (TPTX) rats,
WR-272l or its dephosphorylated analogue did not interfere signifi-
cantly with the calcemic effect and action of bovine PTH (2.5 lU/hr i.v.)
on renal Ca and phosphate handling. However, in TPTX animals a
moderate but significantly larger fall in plasma CA was observed 6 h
after injection (WR-2721: — 0.45 0.04; control: — 0.28 0.05 mM, P
< 0.05). This hypocalcemic effect in TPTX rats was associated with
increased urinary Ca excretion (WR-2721): 172 25, control: 65 13
nmoles/ml GFR), indicating a PTH-independent decrease in tubular Ca
reabsorption. In addition, in both intact and TPTX rats, WR-272l also
induced hypomagnesemia with increased fractional excretion of Mg,
indicating a decrease in tubular Mg reabsorption. In conclusion, WR-
2721 is a unique hypocalcemic agent displaying a strong inhibitory
activity on normal and aberrant PTH secretion with an additional
PTH-independent action on renal Ca reabsorption. This renal effect
could be due to a direct interference of WR-2721 with a transport
system influencing the tubular reabsorption of both calcium and
magnesium.
Incorporation and effect of aluminum in osteomalic vs. osteofibrotic
bone. T. Hess, K. Gautschi, H. Jungbluth, and U. Binswanger.
Nephrologische Station, Departement für Innere Medizin, Universitht
Zurich, Zurich, Switzerland. Osteomalacia (OM) and osteofibrosis (OF)
were induced in growing rats by feeding a low calcium, low phosphorus,
vitamin D poor diet or a calcium deficient diet for 2 weeks. Both diets
were then supplemented with Al Cl3 0.1% and given for another 2
weeks, when the animals were sacrificed and serum and bones ana-
lyzed. Results are as follows (M so; N = 5 for each group):
Osteofibrosis Osteomalacia
Serum Al, ,agmole/lirer 2.20 0,68 2.52 1.01
Ca, mmole/Iiter 2.27 0.18 2.90 0.07
P, mmole/liter 2.65 0.31 0.43 0.12
Bone Al, mmole/JOO g* 0.13 0.04 0.19 0.03
Ca, m,nole/g* 9.70 0.27 10.23 0.58
P, mmole/g* 6.53 0.23 6.36 0.32
Mi, 6% 46.51 2.55 44.85 1.83
* Bone ash. Mi: mineral weight.
Injections of desferrioxamine (DO) 2 x 40 mg per kg body wt 24 and 12
hrs before sacrifice resulted in a decrease of the aluminum by 21% and
an increase of the % mineral content by 20% in osteomalacic animals
only. The aluminium uptake of bone depends on pre-existing pathology.
Removal of aluminium by DO is followed by a rapid mineral
incorporation.
Cyclosporin therapy after renal transplantation: Low-dose is a safe
alternative. N. Gilliard, M. J3urnier, and J. P. Wauters. Division of
Nephralogy, University Hospital, Lausanne, Switzerland. To avoid the
nephrotoxicity as well as the other side effects induced by cyclosporine
(CyA), a very low CyA dosage, aiming at trough blood levels between
100 to 400 nglml, was instituted. After renal cadaveric transplantation,
21 patients were treated with the association of CyA and decreasing
low-dose prednisone (0.7 mg/kg/day). The control group consisted of
the previous 18 patients treated with prednisone and azathioprine.
Routine administration of methylprednisolone on day 0, 2, 7 and 14 and
treatment of acute rejection episodes were identical in both groups.
There were no differences in age, sex, causes of renal failure, and HLA
matching in the two groups. At the time of the study, the mean trough
blood CyA level was at 325 94 ng/ml (range 160 to 440 nglml). No
deaths occurred in the CyA group and one in the conventional therapy
group. Three graft failures occurred in the CyA group, one due to
immediate necrosis of the graft, the other due to acute rejection in two
hyperimmunized patients (second graft, lupus nephropathy). Fifteen
episodes (range 0 to 3) of acute rejection occurred in 10 of the 21
patients treated with CyA (0.7 episode/patient). In the control group, 19
acute rejection episodes occurred in 13 patients (1.05/patient) and four
patients lost their graft after the rejection episode. One-year actuarial
graft survival was 80% in the CyA group and 67% in the control group.
At the time of the study, the mean plasma creatinine level was 137 12
mo1e/liter in the CyA group and 127 12 smo1e/liter in the control
group. Only two patients treated with CyA had creatinine levels above
200 imole/liter. In the three patients in whom a renal biopsy was
performed, no lesions of CyA toxicity were observed. Hirsutism was
the only side effect observed so far. Conclusion: the use of a very low
cyclosporin dosage allows to obtain a good graft survival, a reduction in
the frequency and severity of acute rejection episodes, and serum
creatinine levels comparable to those obtained with conventional
therapy.
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Urinary clearance of cadmium-metallothionein in the rat. A. Borgeat
and J. Diézi. Institut de Pharmacologie de l'Université, CH-10ll
Lausanne, Switzerland. The urinary clearance of cadmium-metallo-
thionein (Cd-MT), isolated from livers from rats exposed to Cd and
infused i.v, to anesthetized animals, was measured during 2 periods of
20 mm each. The amount of Cd-Mt infused was 9.8 mole Cd/kg/mm.
A control group received a similar amount of inorganic Cd. Since Cd/Mt
tubular reabsorption might occur through endocytosis, possibly follow-
ing binding to specific sites in the luminal membrane of proximal
tubules, we studied an additional group of animals infused with similar
amounts of Cd-MT and, concomitantly, with I ,5-diaminopropane
(cadaverine: cdv; 124 molIkg/min), a compound reported to inhibit
protein internalization. Results show that, within the range of filtered
loads of Cd-MT obtained (2.2—5 tg Cd/kg/mm), fractional reabsorption
of Cd-MT remained nearly constant, averaging 65% of the amount
filtered, without indication of a saturation of the reabsorptive transport.
Cdv did not appear to affect Cd-MT reabsorption. Fractional excretion
of ultrafiltratable Cd during inorganic CD infusion averaged 1.5% (vs.
35% during Cd-MT infusion). Cd concentrations in renal cortex at the
end of clearance periods averaged 18.4 jsg/g w.w. after Cd-MT infusion,
and 0.4 g/g w.w. after inorganic Cd infusion. Thus, Cd urinary
clearance and renal cortex concentrations are markedly increased when
Cd is administered as a complex with Cd-MT, and no reabsorptive
maximal transport of Cd-MT occurred at the tubular loads obtained.
Extracapilary proliferative glomerulonephritis after therapy with Co-
Trimoxazol a drug-induced glomerulonephritis? H. R. Burger and G.
Keusch. Institul für Pathologie and Nephrologische Station, Univer-
sitatsspital, Switzerland. Drug-induced glomerulonephropathy is well
known to occur after therapy with gold and penicillamine. Other drugs
have been reported to cause glomerulonephritis (GN) less frequently.
We present five patients (three males and two females, 20 to 70 yrs),
who developed GN with acute renal failure a few days to 1 month after
therapy with Co-Trimoxazol (Co-Tn). Four patients had increased
levels of serum creatinine; one patient was anuric. Kidney biopsy
specimens of all five patients revealed extracapillary proliferative focal
or diffuse GN. In addition, a necrotizing vasculitis was found in one
case. The renal function of this patient improved after therapy with
prednisone and cyclophosphamide; however, he died I month later of
pneumonia. In another patient, creatinine levels decreased to normal
values without steroid therapy, although all of the 15 glomeruli present
in the kidney biopsy had shown extracapillary proliferation. In this
patient, a vasculitis had been diagnosed previously in a skin biopsy. A
third patient suffered from Stevens-Johnson syndrome in addition to the
ON and died of pseudomonas sepsis. The two remaining patients are
alive, but their kidney function is still reduced. Immunofluorescence
studies revealed 1gM in the mesangium in one case, while in another
mesangial depositions of IgA could be demonstrated, Two other biop-
sies were negative for all the sera tested, and in one biopsy specimen,
no glomeruli were available for immunfluorescence studies. Ultrastruc-
turally, intramembranous, hump-like subepithelial and mesangial
electron-dense deposits were present in only one case. Serologic tests
were performed in three patients. Only in one case IgE-antibodies
against Co-Tn could be demonstrated. In another case, circulating
immune complexes with IgA were present. All other parameters tested
(C31C4), antinuclear- and anti.DNA-antibodies, lymphocyte-stimulation
test) turned out to be negative. It is very difficult to prove that Co-Tn is
involved in the pathogenesis of the lesions described above. However,
the close relationship of Co-Tn medication and renal failure in combi-
nation with the consistent finding of extracapillary GN is strongly
suggestive of a drug-induced lesion,
Glomerular filtration rate in the first year of life. P. Alinei and J.-P.
Guignard. Service de Pédiatrie, CHUV, loll Lausanne, Switzerland.
The standard clearance of inulin remains the definitive estimate of GFR,
but is technically demanding. Alternative methods have been proposed,
but their reliability in infants remains to be proven. Glomerular filtration
rate was assessed in 80 infants younger than 1 yr of age, investigated for
possible renal disease. Various estimates of GFR, by endogenous
markers or by indirect methods, without urine collection, were com-
pared to standard inulin clearances (GFR). Clearance studies were
performed in the morning over 4 hr. Inulin was infused at a constant
rate to maintain plasma concentrations close to 30 mg/dl. Urine and
plasma creatinine were measured by the Technicon AutoAnalyzer
method. Values of GFR ranged from 17 to 137 mI/mm per 1.73 m2, 1)
Creatinine clearance values overestimated standard inulin clearance at
almost all levels of GFR (Y = 25.1 + 0.75X, r = 0.77). 2) Clearance
values calculated as the sum of twice the creatinine clearance and the
urea clearance, divided by three, overestimated the GFR at low levels
of filtration and underestimated it at high levels (Y = 20.6 + O.66X, r =
0.82). 3) Clearance values derived from plasma creatinine concentra-
tions and height were significantly different from GFR (Y = 37.51 +
0.505X, r = 0.82). 4) Inulin clearance values, without urine collection,
calculated by dividing the inulin infusion rate by its plasma concentra-
tion, differed significantly from the values obtained by the standard
clearance technique (Y = 36.8 + 0.SIX, r = 0.76). The search for more
convenient methods of assessing GFR, obviating the need of accurate
urine collection or the infusion of exogenous markers, demonstrates
that there is no ideal substitute for the traditional inulin clearance when
precise assessment of GFR is required.
Body sodium/blood volume state In normotensive members of
normotensive or hypertensive families. C. Beretta-Piccoli, A. Fischbach-
er, A. RothenbOhler, A. Gerber, and P. Weidmann. Medizinische
Universitatspoliklinik, Berne, Switzerland. Young patients with essen-
tial hypertension have a significant decrease of body sodium. This
abnormality may reflect a primary abnormality of sodium metabolism or
be the consequence of a natrium-independent elevation of arterial
pressure. To investigate this question, the body sodium/blood volume
state was assessed in 31 male normotensive subjects with negative
family history of essential hypertension (FH) and 31 male normotensive
subjects with positive FH. In the group with negative FH, neither
parents nor any existing siblings had previous episodes of hypertension;
they had a normal blood pressure recorded in the month preceding the
study. In the group with positive FH, at least one or both parents or any
existing siblings had essential hypertension. Subjects with negative or
positive FH were comparable in mean age (24 3 (sn) vs. 25 3 yrs),
body wt (71.1 6.3 vs. 72,3 7.1 kg) or height (178 6 vs 179 6
cm), urinary sodium (160 56 vs. 149 69 mmole/24hr) or potassium
(72 19 vs. 75 24 mmolef24hr), plasma sodium, potassium and
creatinine clearance (98 18 vs. 102 18 mI/mm/I .73 m2). Exchange-
able body sodium (3044 242 vs. 3113 306 mmole), total plasma
(2734 351 vs. 2835 358 ml) or blood volume (4769 579 vs. 4902
581 ml) were also, on average, comparable between normotensive
subjects with negative or positive FH. However, blood pressure tended
to be higher in the latter (113/74 11/9 vs. 122/78 9/8 mm Hg; P <
0.05 for systolic blood pressure). The present findings suggest that the
body sodium/blood volume state is normal in nonmotensive subjects
with positive family history of essential hypertension. Sodium metab-
olism does not appear to represent a familial component in the patho-
genesis of essential hypertension.
Steroid-induced adrenal suppression. A risk factor for kidney graft
rejection? H. A. Bock, F. P. Brunner, J. J. Staub, and G. Thiel.
Departement Innere Medizin, Kantonsspital Base!, Switzerland. In our
current immunosuppressive protocol for kidney transplants(cyclosporine + low dose prednisone), the single morning dose of
prednisone is tapered slowly from 0.5 mg/kg/day to either 0.1 mg/kg/day
(in second transplants or whenever creatinine stays above 200 /.LM/liter)
or none. Rejection episodes are treated with 0.5 g iv. methylprednis-
olone pulses. Since we occasionally observed rejection episodes at the
time of reducing prednisone below 0.1 mg/kg/day (the equivalent of
average endogenous glucocorticoid production), we prospectively mon-
itored adrenal function by performing an ACTH-test (0.25 mg
Synacthen® i.v. between 7 and 9 am) in every patient once he had been
on 0.1 mg/kg/day prednisone for 2 weeks. The test was considered
abnormal if plasma cortisol (RIA) prior to ACTH was < 200 nM/liter, or
did not rise above 550 nM/I at 60 mm after ACTH. Symptoms of adrenal
insufficiency were screened by a questionnaire and a visual analogue
scale. Results of a preliminary evaluation are summarized below (
5EM): Thus, there was evidence of adrenal suppression in some 40% of
our patients. Compared to the group with normal ACTH tests, these
patients had a significantly higher creatinine at follow-up, while there
was no such difference at the time of the ACTH test. These patients also
tended to experience more afternoon fatigue (P < 0.10), which could
indicate that adrenal insufficiency was unmasked once the effect of
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ACTH test: Normal Abnormal P value
Total patients 16 11
Age, yr 50 2 48 4 NS
Mean daily steroid dose
until test, mg/kg/d 0.54 0.05 0.56 0.08 NS
Days from transplanta-
tion to ACTH test 182 34 184 28 NS
Days from ACTH test
to evaluation 158 19 169 24 NS
Creatinine on day of
ACTH test 151 14 180 18 NS
Creatinine at date of
evaluation 157 15 250 40 P < 0.02
Rejections/patient be-
fore ACTH test 1.6 0.4 1.6 0.4 NS
Rejections/patient after
ACTH test 0.6 0.2 1.4 0.5 NS
morning prednisone had worn off. We suspect that patients with
suppressed adrenal glands are at risk to develop impaired graft function,
possibly by clinical or subclinical rejection in periods of insufficient
endogenous steroid secretion. Steroids should be tapered off very
carefully in these patients.
Functional and biochemical aspects of the recovery phase from renal
mineralocorticoid escape in rat. Dominique Chédel and Jacques Diézi.
Institut de Pharmacologie de l'Université, 1001 Lausanne, Switzerland.
Escape to the anti-natnuretic effects of mineralocorticoids is known to
occur following repeated hormone administration. In the present stud-
ies, we investigated the time-course of reappearance of the anti-
natriuretic and kaliuretic effects of small doses of aldosterone (A)
during the recovery phase of escape. Adrenalectomized rats were
infused continuously via osmotic minipumps with A (250 sg/kg/day)
during 4 days. Escape was shown to occur within 24 hr. Minipumps
were then removed, rats were anesthetized and A at "physiological"
dose (2 sglkglhr) was infused iv. (with low dose of dexamethasone).
Subsequently, Na, K, and inulin clearances were measured during 8
30-mm periods. These measurements were carried out at various times
within 24 hr following minipump removal in different groups of rats. We
observed that anti-natriuretic effects of low dose of A did not occur
before 6 hr after minipump removal and was similar, at later times, to
that measured in control, adrenalectomized rats. In contrast, increased
kaliuresis appeared earlier following minipump removal and A infusion
(2.5 hr and later). In addition, we measured the changes in apparent A
binding sites in renal cortex, by Scatchard analysis, within 24 hr after
minipump removal. The number of type I (minearlocorticoid) binding
sites was reduced during escape, but increased after minipump re-
moval. Thus, during recovery from escape, the kaliuretic effect of A
occurs sooner than the anti-natriuretic effect, but both are present
within 6 hrs. The recovery of functional response coincides with an
increase of A binding sites, following "down regulation" in escape.
Effect of verapamil upon the vascular and renal actions of vasopressin
in humans. L. Favre and M. B. Vallotton. Division d'Endocrinologie,
Hôpital Cantonal Universitaire, Geneva, Switzerland. Vasopressin
(AVP) is presumed to act at vascular and renal sites upon different
receptors. To examine the role of calcium in its action, AVP was
infused in six normal females (1 ng/kglmin for 2 hrs after a 2-hr control
period) alone on day 1 and with a concomitant verapamil (V) infusion
(3.6 zg/kg/min for 4 hrs) on day 2. Urine volume, osmolality, prosta-
glandins E2 and F2, were determined for 2-hr periods. V lengthened PR
interval by 53%, increased heart rate, but did not influence mean
arterial pressure (MAP). The slight MAP rise induced by AVP (+ 2.1
1.1 mm Hg; SEM) was reversed by V (—2.2 0.7mmHg, P < 0.01).
By contrast, the changes in urinary osmalality (+411 72 mmole/kg)
and in urinary volume (—600 31 ml) under AVP were not modified by
V (+411 33 mmole/kg, NS; —711 91 ml, NS). V did not change
basal excretion of PGE2 (25 9 vs. 36 5 ng/2hr) and PGF2 (44 5
vs. 45 13 ng/2hr). The trend of AVP to release PGE2 (+36 21 ng/2
hr) was enhanced by V (+83 29 ngl2hr, P < 0.05), whereas the
significant PGF2,. response (P < 0.01) was unchanged (+68 15 vs. 81
13 ng/2hr, NS). In a similar protocol using the non-pressor agonist
dDAVP (0.1 ng/kglmin) instead of AVP, a comparable antidiuresis and
a significant rise in PGE2 and F2 was observed, again unaffected by V.
In conclusion, acute calcium-channel blockade by V reduced the AVP
pressor effect without affecting antidiuresis and renal PG stimulation,
suggesting that transmembrane calcium fluxes are involved in the
vascular but not in these renal actions of AVP.
Creatinine transport by the maturing rabbit kidney. M. Duarte-Silva
and J.-P. Guignard. Service de Pediatrie, Centre Hospitalier
Universitaire Vaudois, 1011 Lausanne, Switzerland. Creatinine clear-
ances are difficult to interpret during the neonatal period, a time when
creatinine transport appears to differ from that present in the mature
kidney. The clearance of creatinine has been compared to that of inulin
in adult and newborn rabbits whose nephrogenesis corresponds to that
of premature infants. Experiments were performed in pentobarbital-
anesthetized, mechanically ventilated animals. Clearance values are
expressed in mi/kg x mm. Group 1: Nine rabbits, aged 5 to 10 days,
were infused with creatinine so as to obtain plasma concentrations of 70
smole/Iiter. Mean inulin clearance (1.34 0.14) significantly (P < 0.02)
overestimated creatinine clearance (1.13 0.09), indicating a 12.6
3.7% fractional reabsorption of creatinine. Group 2: Eleven rabbits,
aged 5 to 10 days, were infused with creatinine so as to obtain a plasma
concentration of 155 smol/liter. Mean inulin clearance (1.39 0.16) did
not significantly differ from creatinine clearance (1.33 0.17). Group 3:
Eight adult rabbits were similarly prepared, but did not receive
exogenous creatinine. Mean endogenous plasma creatinine concentra-
tion was 84 10 mol/liter. Mean creatinine clearance (3.44 0.67)
significantly (P < 0.01) overestimated inulin clearance (2.83 0.49).
Fractional secretion of creatinine was 23.6 2.7%. In the mature
rabbit, creatinine clearance overestimates inulin clearance, indicating
tubular secretion of this endogenous marker. In the immature animal,
creatinine is significantly reabsorbed. These experiments indicate that
creatinine is filtrated and secreted by the mature rabbit kidney, re-
flecting the human situation. The maturing kidney, by contrast, appears
to filter and reabsorb creatinine. This phenomenom is blunted at high
creatinine filtration rates.
Differential effect of impaired renal function on the kinetics of clavu.
lanic acid and ainoxiciftin. F. F. Horber, F. C. Reubi, C. Descoeudres,
A. T. Murray, and F. J. Frey. Medizinische Poliklinik, University of
Berne, Switzerland, and Beecham Pharmaceutical Chemotherapeutic
Research Centre Brockham Park, Betchworth, Surrey, England.
Amoxicillin and the p-lactamase inhibitor clavulanic acid are prescribed
as a fixed drug combination in order to protect amoxicillin from
inactivation by the /3-lactamases of bacteria. The purpose of the present
study was to assess the influence of various degrees of renal insuffi-
ciency (glomerular filtration rate (GFR) < 5 ml/min 1.73 m2 to > 75
ml/min 1.73 m2) on the plasma concentration ratios of amoxicillin to
clavulanic acid following oral (500 mg: 125 mg, amoxicillin:clavulanic
acid) and intravenous dosing (1000 mg:200 mg). The volume of distri-
bution and the systemic availability were independent of the renal
function, while the total body clearance, the renal and the non-renal
clearance of amoxicillin and clavulanic acid decreased with decreasing
renal function. The total body clearance of amoxicillin decreased by a
factor of 10.5 while the total body clearance of clavulanic acid de-
creased only by 3.3. This explains the increase in the ratio of the plasma
concentration vs. time curve of amoxicillin to clavulanic acid with
decreasing glomerular filtration rate: GFR> 75 ml/min 1.73 m2: 4.9
1.2 (ratio of amoxicillin/clavulanic acid after oral dosing); GFR 35—75
ml/min 1.73 m2:5.3 2.4; GFR 10 to 35 mI/mm- 1.73 m2:ll.9 5.8:
GFR 5—10 mI/mm- 1.73 m2: 13.4 9.1; patients on hemodialysis: 14.7
5.3. Thus, if the synergistic effect of the two drugs depends on a
specific ratio of their plasma concentrations, differential dosage adjust-
ments are mandatory in patients with impaired renal function. One fixed
drug combination for all patients would seem to be inadequate.
Development of an animal model of primary hyperparathyroidism PHP
with normocalcemia and normophosphatemia. Ph. Jaeger, W. Jones, M.
Kashgarian, R. Baron, G. V. Segre, andJ. P. Hayslett. Department of
Internal Medicine, University Hospital Lausanne, Switzerland, and
Yale University School of Medicine, New Haven, Connecticut and
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Harvard School of Medicine, Boston, Massachusetts, USA. Previous
studies on the action of parathyroid hormone (PTH) on renal epithelium
have been confounded by marked variations in Ca and P levels,
nephrocalcinosis, and pharmacologic levels of PTH. Studies were
performed in thyroparathyroidectomized (TPTX) rats to determine the
physiologic replacement doses of PTH(lx), and to produce a model of
PHP with 2 to 3x levels of PTH in the absence of changes in plasma Ca
or P and without nephrocalcinosis. Bovine synthetic PTH (1-34) was
infused continuously with the Alzet miniosmotic pump for 6 days.
Infusion of 0.7 lU/hr to animals on a normal diet (Group 1) resulted in
plasma levels of Ca, P, and HCO3, arterial pH, and a score of
nephrocalcinosis (Ca-Nephr) that were not different from normal intact
animals (Group 2). Administration of 2.1 IU/hr(3x) induced severe
stable hypercalcemia, hypophosphatemia, metabolic alkalosis, and
nephrocalcinosis (Group 3). In contrast, all measured parameters were
maintained at levels not different from Group 1 when bPTH (2.1 IU/hr)
and CI2MDP (lOmg/kg/d) were infused in animals on a calcium- and
phosphorus-free diet started 14 days prior to TPTX (Group 4). CI2MDP
alone did not prevent these changes (Group 5).
Conclusion: This model provides a means to analyze the action of PTH
on renal epithelium under chronic conditions, at levels that mimic
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primary hyperparathyroidism in man.
Oxalosis in infancy: Report of four cases. E. F. Leumann, K.
Baerlocher, A. Fanconi, B. Hadorn, A. Niederwieser, L. Pfister, and F.
C. Sitzmann. Universitdtskinderkliniken Zurich, Graz, Homburg und
Kinderkliniken St. Gallen und Winterthur. Primary hyperoxaluria type
I (PH I) with severe clinical manifestations early in life, until recently
thought to be very rare, was observed in four infants who showed poor
weight gain before the age of 3 months. Three patients were severely
acidotic, anemic, and already in renal failure when admitted at 4 to 5
months of age. Patient 4 had mild metabolic acidosis with microscopic
hematuria and leucocyturia; echogenicity of the renal pyramids was
already increased in 3 weeks of age. Two infants had retinal pigmenta-
tion. Diagnosis of PHI was confirmed by high urinary excretion rates of
oxalate (270 to 2040 mmole/mole creatinine; normal < 86) and of
glycolate (400 to 1730 mmole/mole creatinine; normal < 64). Adminis-
tration of pyridoxine (300 mg/day) so far has had no effect on oxalate
excretion. One infant died at 5 months, two were alive in renal failure
at 2 1/2 and 1 1/2 years, respectively, whereas patient 4 is well and still
has good renal function at 6 months. PH I in infants is clinically but not
biochemically distinct from PH I in older children in that hyperoxaluria
leads to early renal failure without urolithiasis. Prognosis has so far
been extremely poor: 81% of 22 cases reported were in end-stage renal
failure before the age of 1 yr. Ultrasound examination should allow
early diagnosis and hopefully treatment will improve the prognosis.
Pharmacokinetic and pharmacodynamic interaction between furose-
mide and metolazone. C. Marone, F. Muggli, F. J. Frey, Ospedale San
Giovanni, Bellinzona and Medizinische Poliklinik, University of Berne,
Switzerland. In various clinical situations (congestive heart failure, liver
cirrhosis, nephrotic syndrome), the diuretic response to high doses of
furosemide is reduced. This can be improved by the addition of
metolazone. The mechanism of this synergistic effect is still unclear.
The purpose of the present investigation was to establish whether
metolazone changes the pharmacokinetics of furosemide and by this
mechanism enhances the diuretic effect. Eight volunteers were given an
intravenous infusion of 4 mg/hr of furosemide for 12 hrs. After 6 hrs, 2.5
mg of metolazone were administered orally. Blood and urine for the
determination of sodium, potassium, chloride, calcium, and furosemide
were collected at hourly intervals. The addition of metolazone in-
creased diuresis from 443 119 (SD) ml/hr to 528 96 mI/hr (P < 0.05),
the urinary excretion of sodium from 57 14 mmole/hr to 74 15
mmole/hr (P < 0.01), and chloride from 65 5 to 78 4 mmole/hr (F
< 0.01), but decreased the urinary excretion of calcium from 0.85
0.10 to 0.57 0.09 mmole/hr (P < 0.01), while urinary furosemide
excretion remained unchanged. Total body clearance, renal clearance,
and nonrenal clearance of furosernide were similar before and after the
administration of metolazone. Conclusion: Our data confirm the addi-
tive diurectic effect of the combination treatment metolazone-furose-
mide and show for the first time a clear hypocalciuric action of
metolazone, similar to thiazides. Moreover, the enhanced diuretic
effect cannot be explained by changes in the metabolism andlor urinary
excretion of furosemide as a consequence of the administration of
metolazone.
Acute interstitial nephritis with iridocyclitis; A newly recognized entity.
J. Nemeth, E. P. Leumann, and J. Briner. Universitats-Kinderklinik
und Institut fur Fathologie der Universität, Zurich, Switzerland. A
14-year-old obese boy presented with a 6-week history of fatigue,
polyuria, and glycosuria. On admission, he was in non-oliguric renal
failure (maximum serum creatinine 1360 mole/liter), afebrile and
normotensive. There was moderate proteinuria (1 g/liter), glycosuria (5
g/liter) and generalized aminoaciduria. The urine contained 5 RBC and
25 WBC/hpf. Renal biopsy showed acute interstitial nephritis with
massive mononuclear cell infiltratin. No etiology was found. The
patient required hemodialysis (5x) and responded dramatically to
therapy with prednisone (75 mg daily for 12 days), which was decreased
rapidly and discontinued after 2 months. He presented again shortly
therafter with ii-idocyclitis of the right eye, and 2 months later with the
same condition in the left eye. Response to local application of steroids
was slow. The association of interstitial nephritis with iridocyclitis has
been observed increasingly during the last few years; the etiology is not
known. As manifestations do not always occur simultaneously, diag-
nosis can sometimes only be made in retrospect.
Glomerulonephritis (GN) associated with chronic bacterial infection.
W. Probst and A. Blumberg, Kantonsspital Aarau, Switzerland.
Glomerular lesions can occur as a consequence of infectious processes.
The GN associated with subacute bacterial endocarditis and so-called
shunt nephritis are well-known examples. In 1976, Beaufils et al (N Engl
J Med 295:185) demonstrated an association between pyogenic ab-
scesses and GN. This report describes five cases of GN occurring after
chronic pyogenic infections (See table). Staphylococci were the infec-
Site of infection Histology (urine) Outcome*
Osteomyleitis Proliferative GN + Improvement after anti-
hip interstitial nephntis biotics (Cr 1390 —*
490)
Femoro-popliteal Proliferative GN Death (septicemia, renal
bypass failure)
Ilio-femoral by- (Proteinuria, red cell Oliguric renal failure
pass casts) Recovery after drainage
Osteomyelitis Mesangioproliferative Improvement after surgi-
hip GN with crescents cal drainage (Cr 930 —
420)
Purulent arthritis (Proteinuria, hema- Improvement after surgi-
shoulder tuna, granular
casts)
cal drainage (Cr 628 —*
280)
* Cr = serum creatinine moles/liter.
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tious agent in all. The patients (pts) exhibitd the classical signs of GN
and after various intervals developed renal insufficiency. In three pts,
UN, predominantly of a proliferative type was confirmed histologically.
It is generally thought that this form of GN is immune-complex induced.
In our pts, immunological studies (not performed in all) were normal,
except a low C3 level in one. infection-associated GN is of special
importance because a rapid and complete cure of the infection will lead
to a recovery or an improvement of renal function. Accordingly, in the
five pts, the evolution of renal function correlated with the success or
failure to control infection.
Value of urinary sediment in the diagnosis of interstitial rejection in
renal transplants. P. Sandoz, D. Bielmann, M. Mihatsch, and G. Thiel.
Nephrologische Abteilung, Departement fur Innere Medizin, und
Pathologisches Institut, Kanionsspital, Base!, Switzerland. Since the
beginning of renal transplantation, urinary sediments have been ana-
lyzed and occurrence of lymphocytuna or a sharp increase in pre-
existing lymphocyturia has been found to correlate with immunologic
rejection. Most studies used time-consuming staining techniques so that
the results were not immediately available. A new staining technique
with prestained slides is investigated as a predictor of cellular rejection
and to distinguish between cellular rejection and cyclosporin (CyA)
toxicity or ischemic renal damage. In 18 consecutive renal transplant
recipients treated with CyA, urinary sediments were analyzed almost
daily for 2 months and prediction of cellular rejection related to renal
biopsies and retrospective clinical evaluation. In addition, 24 transplant
biopsies were compared with urinary sediment prediction; in both parts
of the study, a lymphocyturia of more than 20% and polymorphs less
than 55% (in 100 nucleated cells, excluding squamous epithelial cells)
were considered suggestive for interstitial rejection. Episodes of
lymphocyturia (> 20%) with simultaneous increase of the number of
epithelial cells, resulting in a relative decrease of polymorphs (< 55%),
were found 10 times, eight corresponded well with biopsy or clinical
evaluation, one was false positive, and one remained unclear. Corre-
lating urinary sediment analysis with biopsy histology (N = 24), 19 were
accurate, three equivocal, and two false; this corresponds to a sensi-
tivity of 77% and a specificity of 91%. In conclusion, the analysis of
urinary sediments with prestained slides is a quick and simple method
to diagnose cellular rejection and to distingish it from toxic or ischemic
renal damage. Results are comparable with those of fine needle aspira-
tion technique without invasive insult to the patient.
Solubilization and reconstitution of the renal phosphate (P1) trans-
porter. C. Schäli andD. D. Fanesril. Department of Medicine, Division
of Nephrology, University of California San Diego, La Jolla, Cal ifor-
nia, USA. Proteins from brush border membrane vesicles (BBMV) of
rabbit kidney cortex were solubilized with 1% Octylglucoside at a
protein to detergent ratio of 1:4 w/w. The solubilized proteins (80.2
2.3% of the original brush border proteins, N = 10, mean SE) were
reconstituted by a detergent dialysis method into artificial membrane
vesicles or liposomes, consisting of 80% purified egg yolk phosphati-
dylcholine and 20% cholesterol. Pi transport into the proteoliposomes
was measured by a rapid filtration method, in the presence of a Na or
K gradient (100 mri, out to in). The initial uptake rates of Pi were
significantly faster in the presence of a Na gradient (0.504 0.126
nmole P1/mg protein/mm) than in the presence of a K gradient (0.150
0.045) (N = 3, mean SD). Twenty to 30% of the uptake values
represented Na-dependent transport of Pi into an osmotically sensitive
intravesicular space, the remaining of the uptake representing Na-
independent Pi binding, presumably to the lipidic moiety of the lipo-
somes. The Nat-dependent Pi transport as well as the Nat-independent
Pi binding were both inhibited by arsenate, a competitive inhibitor of
the Pi transport in BBMV. The initial Na-dependent transport rate of
Pi in control liposomes (0.354 nmole Pi/mg protein/mm) was reduced to
0.108 and 0 nmole Pi/mg protein/mm in the presence of 1 and 10 mM
arsenate, respectively. Natdependent Pi transport was not observed
when the liposomes were reconstituted with a detergent extract of
BBMV that had been treated previously with papain, a procedure that
destroys Na Pi (but not Na'/D-glucose) co-transport activity in
BBMV. In conclusion, these data present evidence for successful
reconstitution of the Na-dependent Pi transport system of the renal
brush border membrane.
Norepinephrine-dependence of hypertension in hemodialysis patients.
D. Schohn, P. Weidmann, H. A. Jahn, and C. Beretta-Piccoli. Division
of Nephrology, University Louis-Pasteur, Strasbourg, France and
Med. Poliklinik, University of Berne, Switzerland. To investigate
whether a norepinephrine (NE)-related mechanism participates in the
maintenance of high blood pressure (BP) in terminal renal failure,
various factors were assessed before and after 4 weeks of selective
NE-inhibition with the sympathetic neurone blocker debnsoquine in
nine hypertensive (mean age so, 51 13 yrs) and nine normotensive
(44 10 yrs) hemodialysis patients (HDP) and 11 normal subjects (39
15 yrs). On placebo, hypertensive HDP had an increased total blood
volume (P <0.05) and exchangeable sodium (P < 0.001), and both HDP
groups tended to have higher basal plasma NE, renin activity, and
angiotensin II (All) levels, higher total plasma clearances of NE and
All, and lower BP-responses to infused NE or All than normal
subjects. Plasma epinephnne and the chronotropic dose of
isoproterenol (CDI) did not differ significantly among groups.
Debrisoqumne lowered supine BP markedly in hypertensive HDP (on
average from 181/107 to 148/88 mm Hg) and slightly in normotensive
HDP (143/78 to 131/76 mm Hg), but not in normal subjects (166/74 to
120/79 mm Hg); heart rate was decreased more in the HDP (— 20%)
than in the normal group (— 10%). In all groups, plasma NE, CDI, and
NE pressor dose were reduced in parallel (by 35 to 75%; P < 0.05 to <
0.001), and the relation between stepwise increasing plasma NE and BP
changes during NE infusion was commensurably displaced to the left (P
< 0.01). The remaining parameters were unchanged. Conclusions:
Hypertension in HDP distinctly depends on a NE-related mechanism.
The latter seems to complement the renin-angiotensin system and
sodium-blood volume state in the pathogenesis of high BP. HDP, as
normal subjects, respond to decreased sympathetic outflow with in-
creased alpha and beta-receptor sensitivity. Nevertheless, pharmaco-
logic NE-inhibition is very effective in the therapy of hypertension in
such patients.
Perforated appendicitis in patients undergoing continuous ambulatory
peritoneal dialysis. Report of two cases. K. Vogt, B. Hess, D.
Baumgartner, D. Maass, G. Keusch, and U. Binswanger. Nephrolo-
gische Station, Medizinische Klinik, und Chirurgische Klinik A,
Universitiitsspi:al Zurich, Switzerland. Perforated appendicitis in
CAPD patients is a rarely reported complication. We observed two
cases among 53 patients undergoing CAPD. The diagnosis was delayed
by 18 and 8 days, respectively, after the onset of peritonitic symptoms.
Both patients presented with heavy abdominal pain, diffuse tenderness,
few bowel sounds, fever of 37.5°C up to 39°C, nausea with periodic
vomiting, and poor general condition. The first patient improved
remarkably upon intrapentoneal therapy with Cefazolin, Tobramycin,
Clindamycin, and Vancomycin. After 14 days, abdominal pain resolved
and the leucocyte cell count of the dialysate decreased from initially
l8'OOO to 95/mm3. Two days later the abdominal pain recurred. The
finding of gram-negative organisms in the dialysate led to an exploratory
laparotomy. A perforated, necrotic appendicitis surrounded by an
abscess formation was found. The second patient presented with severe
abdominal pain and clear dialysate which became cloudy only at the
second day of the hospitalization, No organism could be detected in the
dialysate. The peritonitis was resistent to intraperitoneal therapy with
Cefazolin, Tobramycin, Clindamycin, and Vancomycin. The dialysate
leucocyte count increased to 4000 cells/mm3 after I week. After further
clinical deterioration with increased diffuse abdominal tenderness, a
laparotomy was performed; it exhibited a gangrenous and perforated
appendix with only a few adhesions and fibrinous depositions. As in the
previous case, recovery occurred after appendectomy, drainage, re-
moval of the CAPD catheter, and institution of hemodialysis. Accord-
ing to our observations, therapy-resistent peritonitis with variable but
elevated dialysate cell counts and accompanied by diffuse pain and poor
general condition may be due to perforated appendicitis.
Effect of hypercapnic acidosis on renal function in the newborn rabbit.
A. J. V. d. Heyden, M. Thonney, and J.-P. Guignard. Service de
Pédiatrie, CHUV, 1011 Lausanne, Switzerland. Respiratory distress
syndrome is associated with decreased renal function. This effect could
be due to hypoxia, hypercapnic acidosis, and/or hypotension. The
effect of acute hypercapnic acidosis has been studied in neonatal
anesthetized rabbits aged 5 to 12 days, mechanically ventilated with
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different gas mixtures. Inulin and PAH were used as markers of GFR
and renal plasma flow (RPF), respectively. Control normocapnic rab-
bits showed no changes in renal function throughout the experiment.
Acute hypercapnic acidosis (PCO2 = 103 mm Hg, pH = 7.10) induced
a significant decrease in mean arterial pressure (MAP) to 87%, as well
as a decreae in urine volume (to 73%), RPF (to 60%) and GFR (to 80%)
in the first hypercapnic hour. In the second group of hypercapnic
rabbits (PCO2 = 101 mm Hg), infusion of NaHCO3, 0.5 mmole/kg/hr,
slightly corrected the acidemia (blood pH = 7.17) and prevented the fall
in blood pressure, Decreased RPF (to 70%) and GFR (to 87%) were,
however, present. In a third group of animals, induction of moderate
hypercapnia (PCO2 = 80 mm Hg, pH = 7.20) was associated with a
stable MAP, decreased RPF (to 69%), and GFR (to 77%). Filtration
fraction increased significantly in all groups. The calculated renal
vascular resistance increased in all groups to 166%, 152% and 144% in
groups 1, 2, and 3, respectively. These results demonstrate that
hypercapnic acidosis in the newborn rabbit leads to an increase in renal
vascular resistance with a consequent decrease in RPF and GFR. The
vasoconstriction affected by hypercapnia appears to predominate at the
efferent arteriolar level.
Different psychological aspects in patients with end-stage renal failure
according to mode of treatment. B. Wadepuhi, H. Heule and F. Reutter.
Medizinische Kilnik B, Kantonsspital, CH-9007 St. Gallen, Switzer-
land. Sixty patients with ESRD were interviewed about individual,
family, and social strains in order to compare how they adapted to (1)
hemodialysis (HD), (2) continuous ambulatory peritoneal dialysis
(CAPD),and (3) transplantation (TP). Individual reactions, such as
shame and reduced self-security due to impaired body image, were
equal (approx. 20%) in all three groups. In comparison with life prior to
renal replacement therapy (RRT), there was a lower incidence of
depression, anxiety, self-destructive behavior, and withdrawal from
social activities in CAPD patients. Concerning the family strains, HD,
in particular home dialysis, provokes most changes in the family
structure. TP induces fear of surgery and of possible rejection of the
kidney thereafter. Because CAPD patients treat themselves indepen-
dently and have the least dietary restrictions, their families seem to be
less burdened. Social rehabilitation, including employment, social
activities, and interests showed the poorest results in HD patients.
Including housewives, only 15% of patients are working full-time, about
60% part-time, and 25% are unable to work at all. Patients most capable
of working were found in the TP and CAPD groups (approx. 50%
full-time, 50% part-time). Social activities after RRT were drastically
reduced in HD patients, improved slightly in TP patients, and decreased
minimally in CAPD patients. In conclusion, CAPD proves to be a good
alternative to HD concerning the studied psychosociological aspects.
The relative independence and possibility of self-initiative explain the
good results in this group, comparable with those in the TP group. The
study indicates further that some of the problems could be prevented by
adjusting the patients expectations in the preoperative period.
Effects of different dialysis membranes on complement activation and
peripheral blood leucocytes in chronic hemodialysis patients. E.
Wegmuller, C. Descoeudres, and J. Hodler. Medizinische Poliklinik,
Universitat Bern, Switzerland. This study was undertaken to elucidate
to what extent three dialysis membranes, that is, cuprophan (CU),
polyacrilonitrile (PAN), and polymethylmethacrylate (PMC) hollow
fibers, might activate the complement system and cause leukopenia in
chronic hemodialysis patients (CHP). Six CHP were followed prospec-
tively during 4-hr dialysis sessions, utilizing CU during the first, PAN
membranes during the second, and PMC membranes during the third
week of observation. Specific radioimmunoassays were used to quan-
titate the anaphylatoxins, C3a and C5a; the C3d fragment was assessed
by conventional immunodiffusion test, indicating conversion of C3.
Compared to predialysis values, CU membranes significantly increased
C3a, C3d, and C5a concentrations in efferent venous plasma, with
levels peaking 15 mm after begin of dialysis (P < 0.001, <0.02, and <
0.005, respectively). Blood leucocyte counts decreased simultaneously
by 76.5% at 15 mm (P < 0.005); thereafter, complement activation and
leukopenia abated gradually despite continued hemodialysis. The tran-
sient leukopenia correlated inversely with C3a and C5a values in each
individual patient (P < 0.01). By contrast, PMC membranes lead to
moderately increased C3a levels at is mm and C5a levels at 30 mm (P
< 0.05), but C3d remained unchanged, while blood leucocyte counts
dropped slightly by 29.1% (P < 0.05) after 15 mm. PAN membranes
caused neither complement activation nor leukopenia. Thus, cellulosic
membranes (CU) commonly used in extracorporeal bypass systems
induce complement activation and leukopenia. The biocompatibility of
non-cellulosic membranes (PAN and to a smaller degree PMC) seems to
be superior, as reflected by their lack of complement-activating and
leukopenia-inducing potential. The clinical relevance of these findings
remains to be determined.
Prostagiandin (PG) biosynthesis in rat renal tubular coils. Effects of
peptide hormones and osmolality. R. P. Wuthricp, C. Wicht, L. Favre,
and M. B. Vallotton. Division d'Endocrinologie, Hôpital Cantonal
Universitaire, Geneva, Switzerland. The kidney is an important site of
PC synthesis. The evaluate the effect of peptide hormones and the
Ca-ionophore A23l87 on renal PG-production, rat kidneys were
separated into cortex and medulla, The cell suspensions resulting from
dispersion with collagenase were introduced in teflon columns and
superfused with Krebs-Ringer-Bicarbonate-Buffer containing 10-6 M
arachidonic acid (AA). The stimuli were applied during 10 mm at 30 mm
intervals. The tubular cells responded promptly with an increase in the
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PGF2 and PGF production. No 6-keto-PGF1, was detectable. Results;
Mean increments in pg/b6 cells over basal values (PGF2 13.2 for
medulla and 3.8 for cortex, PGF2,, 4.1 for medulla and 1.1 for cortex).
The PGF2 synthesis induced with iO ANG II was blocked by 78.7%
with the ANG Il-antagonist (Sar'-A1a8)-ANG II, when applied at l0
as. When 900 mOsm mannitol or NaCl was applied to cortical cells
during 15 mi mannitol produced a 44.4 + 15.6 pg increase and NaCI
a 59.6 + 16.8 pg increase in PGF2 production (N = 6). The response was
immediate for mannitol, but delayed 20 mm for NaCI. In contrast,
hyperosmolar urea had no effect The response to ANG II and mannitol
or NaCI could be blocked to various degrees with two phospholipase A2
(PLA2)-inhibitors, chloroquine (CQ), and p-bromophenacyl-bromide(p-BPB), when used at iO as. ANG Il-stimulated PGE2 production
was inhibited by 82% with p-BPB and by 74.2% with CQ. These results
show that superfused rat renal tubular cells produce PGs when stimu-
lated with peptide hormones or hyperosmolar mannitol or NaC1,
suggesting a regulatory role for PCs, and that these stimuli act via the
PLA2. ANG II acts mainly on the cortical cells while AVP and BK exert
their effect on the medullary cells.
